Indexes



Press Clippings
"How does a U.S. investor capitalize on Middle East's version of Silicon Valley? You could try the AMIDEX35 Fund"

"First developed as an affinity fund for Jewish-American investors, The AMIDEX35 is proving to be a real winner for others as well."

For Additional Clippings, Click Here.r



Financial Data
date


Name:
The AMIDEX35 Index
Code:
AMDEX
Description:
The AMIDEX35 Index is an equity benchmark for Israeli companies traded on the Tel Aviv Stock Exchange (TASE) and on Wall Street.
Rationale:
The primary Israeli benchmarks, the TA25 and the TA100, are calculated and published by the Tel Aviv Stock Exchange, and focus only on the stocks of Israeli companies traded in Israel. These existing benchmarks therefore fail to capture the impact of the billions of dollars currently invested in other Israeli companies traded in the U.S.
Background:
The Index accommodates two different time zones, currencies, trading rules, price measuring methods and tax systems. The Index-participating companies represent about 60% of the value of all publicly traded Israeli companies in a broad array of sectors, from banking to high-tech, from retail to pharmaceuticals, from telecommunications to chemicals.
Methodology:
The AMIDEX35™ is a market capitalization weighted index, consisting of the 35 highest capitalized Israeli companies publicly traded on the TASE, NASDAQ, or NYSE. Bloomberg L.P. independently calculates and publishes the AMIDEX35™ Index.

The AMIDEX Investment Services Index was developed and is owned by TransNations Investments, LLC, the developer of the AMIDEX35 Index of Israeli stocks, and the AMIDEX Israel Technology Index, the benchmark for Israeli technology stocks traded on the NASDAQ.

Indexes are not investment products available for purchase. Check back to this site often for updates about investment products based on TNI’s indexes.

Amidex Video Highlights
Best viewed with Windows Media Player.
Click here to download

Amidex Radio Highlights
Invest On-Line

Powered By
Please note that past performance is no guarantee of future results. There is not guarantee that performance is no guarantee that the Fund will achieve its objective of replicating 95% of the AMIDEX35 Index performance. Index performance may materially differ from the AMIDEX35 Mutual Fund.

Performance data is for the no-load series. The fund changes 2% redemption fee for amounts withdrew within 365 days of investment. The fund charges a 12 (b) (1) FEE OF 0.25%. For detailed information about fees and expenses, please obtain a prospectus by calling the fund's distributors at 1-888-876-3566.